journal article·2022-03-16

Polydimethylsiloxane Membranes Incorporating Metal–Organic Frameworks for the Sustained Release of Antibacterial Agents

Mofei Shen, Xinyu Liao, Yunlei Xianyu, Donghong Liu, Tian Ding

ACS Applied Materials & Interfaces· Volume 14· Issue 10
Publisher page

Abstract

Cyclodextrin metal–organic frameworks (CD-MOFs) possess great potential in environmental applications due to their high specific surface area and good biocompatibility properties. However, the hydrophilicity of the CD-MOF hinders its ability to maintain a sustained release in water as a carrier. In this study, we prepared a CD-MOF that has codelivery ability for both phytochemicals [caffeic acid (CA)] and silver nanoparticles (Ag NPs) and further incorporated this material (CA@Ag@CD-MOF) into the polydimethylsiloxane (PDMS) matrix to construct a hybrid membrane. This hybrid membrane could effectively maintain the release capacity of the CD-MOF in water, while endowing PDMS with swelling ability in water. The hybrid membrane can achieve a sustained release for up to 48 h in water. In addition, the elastic modulus of the hybrid membrane increases by nearly 100%, and the swelling degree of the hybrid membrane in water increases by 42% compared with that of the pure PDMS membrane, indicating better mechanical properties. The hybrid membrane exhibits excellent antibacterial effects on Escherichia coli O157:H7 (E. coli O157:H7) and Staphylococcus aureus (S. aureus). We expect that this work will be beneficial to the delivery research of the CD-MOF in more environmental scenarios, especially in water treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Membrane Separation Technologies · Metal-Organic Frameworks: Synthesis and Applications · Antimicrobial agents and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Food Science and Nutrition, Zhejiang University, Hangzhou, Zhejiang 310058, China

Funding

National Natural Science Foundation of China

References (67)

Show source-provided references
1. 10.1016/j.jhazmat.2019.12147610.1016/j.jhazmat.2019.121476 ↗
2. 10.1016/j.jhazmat.2020.12491910.1016/j.jhazmat.2020.124919 ↗
3. 10.1016/j.cej.2019.05.07110.1016/j.cej.2019.05.071 ↗
4. 10.1016/j.jhazmat.2018.09.09110.1016/j.jhazmat.2018.09.091 ↗
5. 10.1111/tmi.1232910.1111/tmi.12329 ↗
6. 10.1016/j.scitotenv.2020.14167310.1016/j.scitotenv.2020.141673 ↗
7. 10.2166/wh.2014.19710.2166/wh.2014.197 ↗
8. Liu J. · 2012 · 1119 · 12910.1021/bk-2012-1119.ch006 ↗
9. 10.1021/ja204233q10.1021/ja204233q ↗
10. 10.1111/1541-4337.1251510.1111/1541-4337.12515 ↗
11. 10.1016/j.drudis.2016.04.00910.1016/j.drudis.2016.04.009 ↗
12. 10.1002/advs.20180152610.1002/advs.201801526 ↗
13. 10.1002/anie.20100234310.1002/anie.201002343 ↗
14. 10.1002/anie.20120254910.1002/anie.201202549 ↗
15. 10.1016/j.ejpb.2018.02.00910.1016/j.ejpb.2018.02.009 ↗
16. 10.1002/smll.20190106510.1002/smll.201901065 ↗
17. 10.1016/j.ijpharm.2020.11940710.1016/j.ijpharm.2020.119407 ↗
18. 10.1016/j.jcis.2019.06.06410.1016/j.jcis.2019.06.064 ↗
19. 10.1016/j.ijpharm.2020.11977710.1016/j.ijpharm.2020.119777 ↗
20. 10.1007/s10853-019-03604-710.1007/s10853-019-03604-7 ↗
21. 10.1021/cr500258910.1021/cr5002589 ↗
22. 10.1002/anie.20120491910.1002/anie.201204919 ↗
23. 10.1039/c9ra03079d10.1039/c9ra03079d ↗
24. 10.1039/c6cc01620k10.1039/c6cc01620k ↗
25. 10.1039/c7cc03471g10.1039/c7cc03471g ↗
26. 10.1021/acsbiomaterials.9b0123310.1021/acsbiomaterials.9b01233 ↗
27. 10.1039/c6nr07593b10.1039/c6nr07593b ↗
28. 10.1007/s12161-018-1389-510.1007/s12161-018-1389-5 ↗
29. 10.1016/j.cej.2020.12557510.1016/j.cej.2020.125575 ↗
30. 10.1016/j.porgcoat.2021.10634210.1016/j.porgcoat.2021.106342 ↗
31. 10.1002/adfm.20180124810.1002/adfm.201801248 ↗
32. 10.1002/jbm.b.3365010.1002/jbm.b.33650 ↗
33. 10.1021/am201352w10.1021/am201352w ↗
34. 10.1021/ja509960n10.1021/ja509960n ↗
35. 10.1039/c9nj03632f10.1039/c9nj03632f ↗
36. 10.1002/slct.20190421210.1002/slct.201904212 ↗
37. 10.1016/j.actbio.2011.09.02210.1016/j.actbio.2011.09.022 ↗
38. 10.1016/j.cej.2019.06.02510.1016/j.cej.2019.06.025 ↗
39. 10.1016/j.ejpb.2015.11.01810.1016/j.ejpb.2015.11.018 ↗
40. 10.1016/j.eurpolymj.2017.06.02710.1016/j.eurpolymj.2017.06.027 ↗
41. 10.1016/j.porgcoat.2018.03.01110.1016/j.porgcoat.2018.03.011 ↗
42. 10.1143/jjap.49.06gm0110.1143/jjap.49.06gm01 ↗
43. 10.1021/acs.cgd.6b0165810.1021/acs.cgd.6b01658 ↗
44. 10.1016/j.ijpharm.2016.09.02910.1016/j.ijpharm.2016.09.029 ↗
45. 10.1016/j.seppur.2017.01.02410.1016/j.seppur.2017.01.024 ↗
46. 10.1039/c5ee02660a10.1039/c5ee02660a ↗
47. 10.1016/j.carbpol.2016.06.03610.1016/j.carbpol.2016.06.036 ↗
48. 10.1007/s11694-020-00690-z10.1007/s11694-020-00690-z ↗
49. 10.1016/j.ijpharm.2018.11.07410.1016/j.ijpharm.2018.11.074 ↗
50. 10.1016/j.jmrt.2020.12.03510.1016/j.jmrt.2020.12.035 ↗
51. 10.1016/j.saa.2007.12.00210.1016/j.saa.2007.12.002 ↗
52. 10.3109/02652048.2015.109453110.3109/02652048.2015.1094531 ↗
53. 10.1002/bio.300710.1002/bio.3007 ↗
54. 10.1002/bio.299610.1002/bio.2996 ↗
55. 10.1021/acs.jafc.8b0184610.1021/acs.jafc.8b01846 ↗
56. 10.1021/acs.iecr.9b0421410.1021/acs.iecr.9b04214 ↗
57. 10.1002/jbm.a.3500510.1002/jbm.a.35005 ↗
58. 10.1016/j.ijpharm.2020.11964910.1016/j.ijpharm.2020.119649 ↗
59. 10.1016/j.molstruc.2014.12.06410.1016/j.molstruc.2014.12.064 ↗
60. 10.1016/j.cej.2020.12532810.1016/j.cej.2020.125328 ↗
61. 10.1016/j.memsci.2015.01.04510.1016/j.memsci.2015.01.045 ↗
62. 10.1016/j.reactfunctpolym.2021.10482510.1016/j.reactfunctpolym.2021.104825 ↗
63. 10.1002/pc.2372110.1002/pc.23721 ↗
64. 10.1016/j.reactfunctpolym.2018.11.01210.1016/j.reactfunctpolym.2018.11.012 ↗
65. 10.1038/s41598-019-54147-510.1038/s41598-019-54147-5 ↗
66. 10.1021/acsomega.0c0091210.1021/acsomega.0c00912 ↗
67. 10.1016/j.scitotenv.2016.02.14110.1016/j.scitotenv.2016.02.141 ↗